Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain

被引:148
作者
Spector, AA [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA
关键词
free fatty acid; lipoprotein; polyunsaturated fatty acid; linoleic acid; alpha-linolenic acid; arachidonic acid; docosahexaenoic acid; phospholipid; blood-brain barrier; astrocyte;
D O I
10.1385/JMN:16:2-3:159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyunsaturated fatty acids (PUFA), which comprise 25-30% of the fatty acids in the human brain, are necessary for normal brain development and function. PUFA cannot be synthesized de novo and must be supplied to the brain by the plasma. It is necessary to know the PUFA content and composition of the various plasma lipids and lipoproteins in order to understand how these fatty acids are taken up and metabolized by the brain. Human plasma free fatty acid (FFA) ordinarily contains about 15 % linoleic acid (18:2n-6) and 1% arachidonic acid (AA) (20:4n-6). Plasma triglycerides, phospholipids, and cholesterol esters also are rich in linoleic acid, and the phospholipids and cholesterol esters contain about 10% AA. These findings suggest that the brain probably call obtain an adequate supply of n-6 PUFA from either the plasma FFA or lipoproteins. By contrast, the plasma ordinarily contains only one-tenth as much n-3 PUFA, and the amounts range from 1% alpha -linolenic acid (18:3n-3) in the plasma FFA to 2% docosahexaenoic acid (22:6n-3, DHA) in the plasma phospholipids. The main n-3 PUFA in the brain is DHA. Therefore, if the plasma FFA is the primary source of fatty acid for the brain, much of the DHA must be synthesized in the brain from n-3 PUFA precursors. Alternatively, if the brain requires large amounts of preformed DHA, the phospholipids contained in plasma lipoproteins are the mostlikely source.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 36 条
[1]   Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid [J].
Bernoud, N ;
Fenart, L ;
Molière, P ;
Dehouck, MP ;
Lagarde, M ;
Cecchelli, R ;
Lecerf, J .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :338-345
[2]  
BRECHER P, 1979, J LIPID RES, V20, P464
[3]   Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy [J].
Connor, WE ;
Lowensohn, R ;
Hatcher, L .
LIPIDS, 1996, 31 :S183-S187
[4]  
Conquer JA, 1998, J LIPID RES, V39, P286
[5]   INTRAVENOUS-INJECTION OF [1-C-14] ARACHIDONATE TO EXAMINE REGIONAL BRAIN LIPID-METABOLISM IN UNANESTHETIZED RATS [J].
DEGEORGE, JJ ;
NORONHA, JG ;
BELL, J ;
ROBINSON, P ;
RAPOPORT, SI .
JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 24 (03) :413-423
[6]   A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier [J].
Dehouck, B ;
Fenart, L ;
Dehouck, MP ;
Pierce, A ;
Torpier, G ;
Cecchelli, R .
JOURNAL OF CELL BIOLOGY, 1997, 138 (04) :877-889
[7]   UP-REGULATION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR AT THE BLOOD-BRAIN-BARRIER - INTERCOMMUNICATIONS BETWEEN BRAIN CAPILLARY ENDOTHELIAL-CELLS AND ASTROCYTES [J].
DEHOUCK, B ;
DEHOUCK, MP ;
FRUCHART, JC ;
CECCHELLI, R .
JOURNAL OF CELL BIOLOGY, 1994, 126 (02) :465-473
[8]  
DeltonVandenbroucke I, 1997, J LIPID RES, V38, P147
[9]  
DEVRIES HE, 1993, J NEUROCHEM, V61, P1813
[10]   BIOSYNTHESIS OF POLYUNSATURATED FATTY-ACIDS IN DEVELOPING BRAIN .1. METABOLIC TRANSFORMATIONS OF INTRACRANIALLY ADMINISTERED 1-C-14 LINOLENIC ACID [J].
DHOPESHWARKAR, GA ;
SUBRAMANIAN, C .
LIPIDS, 1976, 11 (01) :67-71